TY - JOUR
T1 - Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease
AU - Margaroli, Camilla
AU - Horati, Hamed
AU - Garratt, Luke W.
AU - Giacalone, Vincent D.
AU - Schofield, Craig
AU - Dittrich, A. Susanne
AU - Rosenow, Tim
AU - Dobosh, Brian S.
AU - Lim, Hong S.
AU - Frey, Dario L.
AU - Veltman, Mieke
AU - Silva, George L.
AU - Brown, Milton R.
AU - Schultz, Carsten
AU - Tiddens, Harm A.W.M.
AU - Ranganathan, Sarath
AU - Chandler, Joshua D.
AU - Qiu, Peng
AU - Peng, Limin
AU - Scholte, Bob J.
AU - Mall, Marcus A.
AU - Kicic, Anthony
AU - Guglani, Lokesh
AU - Stick, Stephen M.
AU - Janssens, Hettie M.
AU - Tirouvanziam, Rabindra
N1 - Funding Information:
National Institutes of Health (NIH, USA) R01HL126603 (to H.H., M.R.B, B.J.S., H.M.J., L.P., and R.T.); I-BALL monitoring program in Rotterdam and research coordinators are partly funded by Dutch CF foundation (NCFS-HIT-CF); CF@LANTA Research Development Program Fellowship (to C.M.) as funded by the US Cystic Fibrosis Foundation (MCCART15R0); UAB Research Development Program Fellowship (to C.M.) funded by the US CFF (ROWE19R0); CFF Postdoc-to-Faculty Award to C.M. (MARGAR21F5); National Health and Medical Research Council (NHMRC; Australia) 1142505 (to L.W.G, R.T., A.K., and S.M.S.), and Peter Doherty Fellowship 1141479 (to L.W.G.); Western Australian Department of Health Merit Award (to L.W.G.); National Science Foundation (NSF, USA) CCF1552784 (to P.Q.); ISAC Marylou Ingram Scholarship (to P.Q.); the German Ministry for Education and Research (FKZ 82DZL00401 and FKZ 82DZL004A1 to M.A.M.), the German Research Foundation (SFB-TR84TP B08 to M.A.M), the Einstein Foundation Berlin (EP-2017-393 to M.A.M), the German Cystic Fibrosis Association Mukoviszidose e. V. (Project number 1605 to A.S.D.), and the Heidelberg Research Center for Molecular Medicine Career Development Fellowship (to A.S.D.). AREST CF is supported by several sources, including the NHMRC, NIH, US Cystic Fibrosis Foundation Therapeutics, and Cystic Fibrosis Australia. IMPEDE-CF is supported by the CF@LANTA Research Development Program Pilot Fund (to R.T. and L.G.) as funded by the US Cystic Fibrosis Foundation (MCCART15R0).
Funding Information:
We thank all children and parents willing to enroll in the study cohorts in Rotterdam (The Netherlands), Perth (Australia), and Atlanta (USA). For the Erasmus Medical Center we would like to thank the Department of Cell Biology for flow cytometry core services, pediatric pulmonologists for performing bronchoscopies, research coordinators E. van der Wiel and B. Manai for patient inclusion and study management, and the Department of Pathology for providing lipidation slides and data. For the Telethon Kids Institute we would like to thank the flow cytometry core, and for Children's Healthcare of Atlanta and Emory University the pediatric flow cytometry core. We also thank Drs. D. Weiss and D. Hufnagel for assistance with the bacterial killing assay.
Publisher Copyright:
© 2022
PY - 2022
Y1 - 2022
N2 - Background: Macrophages are the major resident immune cells in human airways coordinating responses to infection and injury. In cystic fibrosis (CF), neutrophils are recruited to the airways shortly after birth, and actively exocytose damaging enzymes prior to chronic infection, suggesting a potential defect in macrophage immunomodulatory function. Signaling through the exhaustion marker programmed death protein 1 (PD-1) controls macrophage function in cancer, sepsis, and airway infection. Therefore, we sought to identify potential associations between macrophage PD-1 and markers of airway disease in children with CF. Methods: Blood and bronchoalveolar lavage fluid (BALF) were collected from 45 children with CF aged 3 to 62 months and structural lung damage was quantified by computed tomography. The phenotype of airway leukocytes was assessed by flow cytometry, while the release of enzymes and immunomodulatory mediators by molecular assays. Results: Airway macrophage PD-1 expression correlated positively with structural lung damage, neutrophilic inflammation, and infection. Interestingly, even in the absence of detectable infection, macrophage PD-1 expression was elevated and correlated with neutrophilic inflammation. In an in vitro model mimicking leukocyte recruitment into CF airways, soluble mediators derived from recruited neutrophils directly induced PD-1 expression on recruited monocytes/macrophages, suggesting a causal link between neutrophilic inflammation and macrophage PD-1 expression in CF. Finally, blockade of PD-1 in a short-term culture of CF BALF leukocytes resulted in improved pathogen clearance. Conclusion: Taken together, these findings suggest that in early CF lung disease, PD-1 upregulation associates with airway macrophage exhaustion, neutrophil takeover, infection, and structural damage.
AB - Background: Macrophages are the major resident immune cells in human airways coordinating responses to infection and injury. In cystic fibrosis (CF), neutrophils are recruited to the airways shortly after birth, and actively exocytose damaging enzymes prior to chronic infection, suggesting a potential defect in macrophage immunomodulatory function. Signaling through the exhaustion marker programmed death protein 1 (PD-1) controls macrophage function in cancer, sepsis, and airway infection. Therefore, we sought to identify potential associations between macrophage PD-1 and markers of airway disease in children with CF. Methods: Blood and bronchoalveolar lavage fluid (BALF) were collected from 45 children with CF aged 3 to 62 months and structural lung damage was quantified by computed tomography. The phenotype of airway leukocytes was assessed by flow cytometry, while the release of enzymes and immunomodulatory mediators by molecular assays. Results: Airway macrophage PD-1 expression correlated positively with structural lung damage, neutrophilic inflammation, and infection. Interestingly, even in the absence of detectable infection, macrophage PD-1 expression was elevated and correlated with neutrophilic inflammation. In an in vitro model mimicking leukocyte recruitment into CF airways, soluble mediators derived from recruited neutrophils directly induced PD-1 expression on recruited monocytes/macrophages, suggesting a causal link between neutrophilic inflammation and macrophage PD-1 expression in CF. Finally, blockade of PD-1 in a short-term culture of CF BALF leukocytes resulted in improved pathogen clearance. Conclusion: Taken together, these findings suggest that in early CF lung disease, PD-1 upregulation associates with airway macrophage exhaustion, neutrophil takeover, infection, and structural damage.
KW - Bronchiectasis
KW - Checkpoint inhibition
KW - Cystic fibrosis
KW - Elastase
KW - Immunotherapy
KW - Matrix metalloproteinase
UR - http://www.scopus.com/inward/record.url?scp=85132723409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132723409&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2022.06.001
DO - 10.1016/j.jcf.2022.06.001
M3 - Article
C2 - 35732550
AN - SCOPUS:85132723409
SN - 1569-1993
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
ER -